FDA eases concern about certain diabetes drugs

By  | 

UNDATED (AP) -- People who take Januvia, Byetta or certain other widely prescribed medicines for diabetes can breathe a little easier. U.S. and European regulators say they have found no compelling evidence of a link between these drugs and pancreas problems.

The federal Food and Drug Administration and its European counterpart started reviews last year of these medicines after a study suggested a safety concern. They include Janumet, Victoza, Bydureon and other brands. The drugs help spur insulin production after meals, to help people with Type 2 diabetes break down carbohydrates in food.

In an article in Wednesday's New England Journal of Medicine, FDA and European scientists say their review provides reassurance but that a final conclusion has not been reached and they will continue to investigate concerns.



 
Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus